Skip to content
value.today

Syncardia Systems Inc.

Formerly Syn-Cor Systems, Inc.

Total raised
$15 M
3 rounds on record
Latest round
$6 M
Sep 2014
First round on record
Nov 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Syncardia Systems Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2014$6 MNo. 3$2 to $10 million

Syncardia Systems Inc.: Raise no. 3, Sep 2014

Investors in this round

83 investors had bought by the notice of Oct 14, 2014: 83 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $15 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Douglas A. Nutter · Executive Officer
  • Kirk A. Collamer · Executive Officer
  • Luis A. Burgos · Executive Officer
  • Michael C. Garippa · Executive Officer, Director
  • Doug David Fahoury · Director
  • Eric C. Salzman · Director
  • Harry K. George · Director
  • Jack G. Copeland, M.D. · Director
  • Mark C. Goldberg, M.D. · Director
  • Thomas K. Cox · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kirk A. Collamer, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 14, 2014. Read the notice at the SEC.

equitySEC
Mar 2011$5 MNo. 2$2 to $10 million

Syncardia Systems Inc.: Raise no. 2, Mar 2011

Investors in this round

99 investors had bought by the notice of Mar 28, 2011: 99 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $8 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dena Richter · Executive Officer
  • J. David Mackstaller · Executive Officer, Director
  • Marvin J. Slepian, M.D. · Executive Officer, Director
  • Michael C. Garippa · Executive Officer
  • Rodger G. Ford · Executive Officer, Director
  • Harry K. George · Director
  • Jack G. Copeland, M.D. · Director
  • Mark C. Goldberg, M.D. · Director
  • Mark C. Schlossberg · Director
  • Mark C. Solon · Director
  • Thomas K. Cox · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dena Richter, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 28, 2011. Read the notice at the SEC.

equity, optionsSEC
Nov 2010$4 MNo. 1$2 to $10 million

Syncardia Systems Inc.: Raise no. 1, Nov 2010

Investors in this round

92 investors had bought by the notice of Jan 21, 2011: 92 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dena Richter · Executive Officer
  • J. David Mackstaller · Executive Officer, Director
  • Marvin J. Slepian, M.D. · Executive Officer, Director
  • Michael C. Garippa · Executive Officer
  • Rodger G. Ford · Executive Officer, Director
  • Harry K. George · Director
  • Jack G. Copeland, M.D. · Director
  • Mark C. Goldberg, M.D. · Director
  • Mark C. Schlossberg · Director
  • Mark C. Solon · Director
  • Thomas K. Cox · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dena Richter, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 21, 2011. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Syncardia Systems Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2014).

    SEC Form D · Oct 2014

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2014

That is all the official record says: Syncardia Systems Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Syncardia Systems Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 99 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Syncardia Systems Inc.
NameRoleNamed in
Douglas A. NutterExecutive officerOct 2014
Kirk A. CollamerExecutive officerOct 2014
Luis A. BurgosExecutive officerOct 2014
Michael C. GarippaExecutive officerOct 2014
Dena RichterExecutive officerMar 2011
J. David MackstallerExecutive officerMar 2011
Marvin J. Slepian, M.D.Executive officerMar 2011
Rodger G. FordExecutive officerMar 2011
Doug David FahouryDirectorOct 2014
Eric C. SalzmanDirectorOct 2014
Harry K. GeorgeDirectorOct 2014
Jack G. Copeland, M.D.DirectorOct 2014
Mark C. Goldberg, M.D.DirectorOct 2014
Michael C. GarippaDirectorOct 2014
Thomas K. CoxDirectorOct 2014
J. David MackstallerDirectorMar 2011
Mark C. SchlossbergDirectorMar 2011
Mark C. SolonDirectorMar 2011
Marvin J. Slepian, M.D.DirectorMar 2011
Rodger G. FordDirectorMar 2011